Abstract
Background
Dry eye disease (DED) is one of the most common ocular disorders worldwide. The pathophysiological mechanisms involved in the development of DED are not well-understood, and thus treating DED has been a significant challenge for ophthalmologists. Most of the currently available diagnostic tests demonstrate low correlation to patient symptoms and have low reproducibility.
Methods
Recently, sophisticated in vivo imaging modalities have become available for patient care, namely, in vivo confocal microscopy (IVCM) and optical coherence tomography (OCT). These emerging modalities are powerful and non-invasive, allowing real-time visualization of cellular and anatomical structures of the cornea and ocular surface. Here we discuss how, by providing both qualitative and quantitative assessment, these techniques can be used to demonstrate early subclinical disease, grade layer-by-layer severity, and allow monitoring of disease severity by cellular alterations. Imaging-guided stratification of patients may also be possible in conjunction with clinical examination methods.
Conclusions
Visualization of subclinical changes and stratification of patients in vivo allows objective image-guided evaluation of tailored treatment response based on cellular morphological alterations specific to each patient. This image-guided approach to DED may ultimately improve patient outcomes and make it possible to study the efficacy of novel therapies in clinical trials.
Similar content being viewed by others
References
(2007) The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf 5:75–92
Uchino M, Nishiwaki Y, Michikawa T, Shirakawa K, Kuwahara E, Yamada M, Dogru M, Schaumberg DA, Kawakita T, Takebayashi T, Tsubota K (2011) Prevalence and risk factors of dry eye disease in Japan: Koumi Study. Ophthalmology 118:2361–2367
Han SB, Hyon JY, Woo SJ, Lee JJ, Kim TH, Kim KW (2011) Prevalence of dry eye disease in an elderly Korean population. Arch Ophthalmol 129:633–638
Guo B, Lu P, Chen X, Zhang W, Chen R (2010) Prevalence of dry eye disease in Mongolians at high altitude in China: the Henan Eye Study. Ophthalmic Epidemiol 17:234–241
Chia EM, Mitchell P, Rochtchina E, Lee AJ, Maroun R, Wang JJ (2003) Prevalence and associations of dry eye syndrome in an older population: the Blue Mountains Eye Study. Clin Exp Ophthalmol 31:229–232
McCarty CA, Bansal AK, Livingston PM, Stanislavsky YL, Taylor HR (1998) The epidemiology of dry eye in Melbourne, Australia. Ophthalmology 105:1114–1119
Lin PY, Tsai SY, Cheng CY, Liu JH, Chou P, Hsu WM (2003) Prevalence of dry eye among an elderly Chinese population in Taiwan: the Shihpai Eye Study. Ophthalmology 110:1096–1101
Lee AJ, Lee J, Saw SM, Gazzard G, Koh D, Widjaja D, Tan DT (2002) Prevalence and risk factors associated with dry eye symptoms: a population based study in Indonesia. Br J Ophthalmol 86:1347–1351
(2007) The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf 5: 93–107
Schaumberg DA, Dana R, Buring JE, Sullivan DA (2009) Prevalence of dry eye disease among US men: estimates from the Physicians’ Health Studies. Arch Ophthalmol 127:763–768
Schein OD, Munoz B, Tielsch JM, Bandeen-Roche K, West S (1997) Prevalence of dry eye among the elderly. Am J Ophthalmol 124:723–728
Moss SE, Klein R, Klein BE (2000) Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol 118:1264–1268
Schaumberg DA, Sullivan DA, Buring JE, Dana MR (2003) Prevalence of dry eye syndrome among US women. Am J Ophthalmol 136:318–326
Galor A, Feuer W, Lee DJ, Florez H, Carter D, Pouyeh B, Prunty WJ, Perez VL (2011) Prevalence and risk factors of dry eye syndrome in a United States Veterans Affairs population. Am J Ophthalmol 152:377.e2–384.e2
Moschos MM, Chatziralli IP, Siasou G, Papazisis L (2012) Visual problems in young adults due to computer use. Klin Monatsbl Augenheilkd 229:379–381
Thomson WD (1998) Eye problems and visual display terminals–the facts and the fallacies. Ophthalmic Physiol Opt 18:111–119
Uchino M, Schaumberg DA, Dogru M, Uchino Y, Fukagawa K, Shimmura S, Satoh T, Takebayashi T, Tsubota K (2008) Prevalence of dry eye disease among Japanese visual display terminal users. Ophthalmology 115:1982–1988
Blehm C, Vishnu S, Khattak A, Mitra S, Yee RW (2005) Computer vision syndrome: a review. Surv Ophthalmol 50:253–262
Tsubota K, Nakamori K (1993) Dry eyes and video display terminals. N Engl J Med 328:584
Uchino M, Dogru M, Uchino Y, Fukagawa K, Shimmura S, Takebayashi T, Schaumberg DA, Tsubota K (2008) Japan Ministry of Health study on prevalence of dry eye disease among Japanese high school students. Am J Ophthalmol 146:925.e2–929.e2
Zhang Y, Chen H, Wu X (2012) Prevalence and risk factors associated with dry eye syndrome among senior high school students in a county of Shandong Province, China. Ophthalmic Epidemiol 19:226–230
Pouyeh B, Viteri E, Feuer W, Lee DJ, Florez H, Fabian JA, Perez VL, Galor A (2012) Impact of ocular surface symptoms on quality of life in a United States Veterans Affairs population. Am J Ophthalmol 153:1061.e3–1066.e3
Li M, Gong L, Chapin WJ, Zhu M (2012) Assessment of vision-related quality of life in dry eye patients. Invest Ophthalmol Vis Sci 53:5722–5727
Mertzanis P, Abetz L, Rajagopalan K, Espindle D, Chalmers R, Snyder C, Caffery B, Edrington T, Simpson T, Nelson JD, Begley C (2005) The relative burden of dry eye in patients’ lives: comparisons to a U.S. normative sample. Invest Ophthalmol Vis Sci 46:46–50
Goto E, Yagi Y, Matsumoto Y, Tsubota K (2002) Impaired functional visual acuity of dry eye patients. Am J Ophthalmol 133:181–186
Miljanovic B, Dana R, Sullivan DA, Schaumberg DA (2007) Impact of dry eye syndrome on vision-related quality of life. Am J Ophthalmol 143:409–415
Tong L, Waduthantri S, Wong TY, Saw SM, Wang JJ, Rosman M, Lamoureux E (2010) Impact of symptomatic dry eye on vision-related daily activities: the Singapore Malay Eye Study. Eye (Lond) 24:1486–1491
Le Q, Zhou X, Ge L, Wu L, Hong J, Xu J (2012) Impact of dry eye syndrome on vision-related quality of life in a non-clinic-based general population. BMC Ophthalmol 12:22
Schiffman RM, Walt JG, Jacobsen G, Doyle JJ, Lebovics G, Sumner W (2003) Utility assessment among patients with dry eye disease. Ophthalmology 110:1412–1419
Buchholz P, Steeds CS, Stern LS, Wiederkehr DP, Doyle JJ, Katz LM, Figueiredo FC (2006) Utility assessment to measure the impact of dry eye disease. Ocul Surf 4:155–161
Galor A, Zheng DD, Arheart KL, Lam BL, Perez VL, McCollister KE, Ocasio M, McClure LA, Lee DJ (2012) Dry eye medication use and expenditures: data from the medical expenditure panel survey 2001 to 2006. Cornea 31(12):1403–1407
Reddy P, Grad O, Rajagopalan K (2004) The economic burden of dry eye: a conceptual framework and preliminary assessment. Cornea 23:751–761
Rein DB, Zhang P, Wirth KE, Lee PP, Hoerger TJ, McCall N, Klein R, Tielsch JM, Vijan S, Saaddine J (2006) The economic burden of major adult visual disorders in the United States. Arch Ophthalmol 124:1754–1760
Patel VD, Watanabe JH, Strauss JA, Dubey AT (2011) Work productivity loss in patients with dry eye disease: an online survey. Curr Med Res Opin 27:1041–1048
Yu J, Asche CV, Fairchild CJ (2011) The economic burden of dry eye disease in the United States: a decision tree analysis. Cornea 30:379–387
Akpek EK, Lindsley KB, Adyanthaya RS, Swamy R, Baer AN, McDonnell PJ (2011) Treatment of Sjogren’s syndrome-associated dry eye an evidence-based review. Ophthalmology 118:1242–1252
Friedman NJ (2010) Impact of dry eye disease and treatment on quality of life. Curr Opin Ophthalmol 21:310–316
Fiscella RG (2011) Understanding dry eye disease: a managed care perspective. Am J Manag Care 17(Suppl 16):S432–S439
Luthe R (2010) Dry eye drug development: when will the floodgates open? Ophthalmol Manag
Karpecki P (2013) Why dry eye trials often fail. Review Optom
Caceres V (2011) Treating dry eye. ASCRS Eye World
Epstein SP, Gadaria-Rathod N, Wei Y, Maguire MG, Asbell PA (2013) HLA-DR expression as a biomarker of inflammation for multicenter clinical trials of ocular surface disease. Exp Eye Res 111:95–104
Gipson IK, Argueso P (2003) Role of mucins in the function of the corneal and conjunctival epithelia. Int Rev Cytol 231:1–49
Spurr-Michaud S, Argueso P, Gipson I (2007) Assay of mucins in human tear fluid. Exp Eye Res 84:939–950
Carraway KL, Perez A, Idris N, Jepson S, Arango M, Komatsu M, Haq B, Price-Schiavi SA, Zhang J, Carraway CA (2002) Muc4/sialomucin complex, the intramembrane ErbB2 ligand, in cancer and epithelia: to protect and to survive. Prog Nucleic Acid Res Mol Biol 71:149–185
Gipson IK (2004) Distribution of mucins at the ocular surface. Exp Eye Res 78:379–388
Hodges RR, Dartt DA (2013) Tear film mucins: Front line defenders of the ocular surface; comparison with airway and gastrointestinal tract mucins. Exp Eye Res 117:62–78
Albertsmeyer AC, Kakkassery V, Spurr-Michaud S, Beeks O, Gipson IK (2010) Effect of pro-inflammatory mediators on membrane-associated mucins expressed by human ocular surface epithelial cells. Exp Eye Res 90:444–451
Gipson IK, Hori Y, Argueso P (2004) Character of ocular surface mucins and their alteration in dry eye disease. Ocul Surf 2:131–148
Dartt DA (2004) Interaction of EGF family growth factors and neurotransmitters in regulating lacrimal gland secretion. Exp Eye Res 78:337–345
Knop E, Knop N, Millar T, Obata H, Sullivan DA (2011) The international workshop on meibomian gland dysfunction: report of the subcommittee on anatomy, physiology, and pathophysiology of the meibomian gland. Invest Ophthalmol Vis Sci 52:1938–1978
Shimazaki J, Goto E, Ono M, Shimmura S, Tsubota K (1998) Meibomian gland dysfunction in patients with Sjogren syndrome. Ophthalmology 105:1485–1488
Bron AJ, Yokoi N, Gafney E, Tiffany JM (2009) Predicted phenotypes of dry eye: proposed consequences of its natural history. Ocul Surf 7:78–92
Mizuno Y, Yamada M, Miyake Y (2010) Association between clinical diagnostic tests and health-related quality of life surveys in patients with dry eye syndrome. Jpn J Ophthalmol 54:259–265
Fuentes-Paez G, Herreras JM, Cordero Y, Almaraz A, Gonzalez MJ, Calonge M (2011) Lack of concordance between dry eye syndrome questionnaires and diagnostic tests. Arch Soc Esp Oftalmol 86:3–7
Schein OD, Tielsch JM, Munoz B, Bandeen-Roche K, West S (1997) Relation between signs and symptoms of dry eye in the elderly. A population-based perspective. Ophthalmology 104:1395–1401
Begley CG, Chalmers RL, Abetz L, Venkataraman K, Mertzanis P, Caffery BA, Snyder C, Edrington T, Nelson D, Simpson T (2003) The relationship between habitual patient-reported symptoms and clinical signs among patients with dry eye of varying severity. Invest Ophthalmol Vis Sci 44:4753–4761
Barboza MN, Barboza GN, de Melo GM, Sato E, Dantas MC, Dantas PE, Felberg S (2008) Correlation between signals and symptoms of dry eye in Sjogren’s syndrome patients. Arq Bras Oftalmol 71:547–552
Nichols KK, Nichols JJ, Mitchell GL (2004) The lack of association between signs and symptoms in patients with dry eye disease. Cornea 23:762–770
Blackie CA, Korb DR, Knop E, Bedi R, Knop N, Holland EJ (2010) Nonobvious obstructive meibomian gland dysfunction. Cornea 29:1333–1345
Nelson JD, Shimazaki J, Benitez-del-Castillo JM, Craig JP, McCulley JP, Den S, Foulks GN (2011) The international workshop on meibomian gland dysfunction: report of the definition and classification subcommittee. Invest Ophthalmol Vis Sci 52:1930–1937
Cuevas M, Gonzalez-Garcia MJ, Castellanos E, Quispaya R, Parra Pde L, Fernandez I, Calonge M (2012) Correlations among symptoms, signs, and clinical tests in evaporative-type dry eye disease caused by Meibomian gland dysfunction (MGD). Curr Eye Res 37:855–863
Viso E, Rodriguez-Ares MT, Abelenda D, Oubina B, Gude F (2012) Prevalence of asymptomatic and symptomatic meibomian gland dysfunction in the general population of Spain. Invest Ophthalmol Vis Sci 53:2601–2606
Adatia FA, Michaeli-Cohen A, Naor J, Caffery B, Bookman A, Slomovic A (2004) Correlation between corneal sensitivity, subjective dry eye symptoms and corneal staining in Sjogren’s syndrome. Can J Ophthalmol 39:767–771
(2007) Methodologies to diagnose and monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf 5: 108–152
Nichols KK, Zadnik K (2002) The repeatability of diagnostic tests and surveys in dry eye. Adv Exp Med Biol 506:1171–1175
Nichols KK, Mitchell GL, Zadnik K (2004) The repeatability of clinical measurements of dry eye. Cornea 23:272–285
Johnson ME, Murphy PJ (2005) The agreement and repeatability of tear meniscus height measurement methods. Optom Vis Sci 82:1030–1037
Lemp MA, Bron AJ, Baudouin C, Benitez Del Castillo JM, Geffen D, Tauber J, Foulks GN, Pepose JS, Sullivan BD (2011) Tear osmolarity in the diagnosis and management of dry eye disease. Am J Ophthalmol 151:792.e1–798.e1
Sullivan BD, Whitmer D, Nichols KK, Tomlinson A, Foulks GN, Geerling G, Pepose JS, Kosheleff V, Porreco A, Lemp MA (2010) An objective approach to dry eye disease severity. Invest Ophthalmol Vis Sci 51:6125–6130
Tomlinson A, Khanal S, Ramaesh K, Diaper C, McFadyen A (2006) Tear film osmolarity: determination of a referent for dry eye diagnosis. Invest Ophthalmol Vis Sci 47:4309–4315
Versura P, Profazio V, Campos EC (2010) Performance of tear osmolarity compared to previous diagnostic tests for dry eye diseases. Curr Eye Res 35:553–564
Amparo F, Jin Y, Hamrah P, Schaumberg DA, Dana R (2014) What is the value of incorporating tear osmolarity measurement in assessing patient response to therapy in dry eye disease? Am J Ophthalmol 157:69.e2–77.e2
Kerimoglu H, Ozturk B, Gunduz K, Bozkurt B, Kamis U, Okka M (2010) Effect of altered eating habits and periods during Ramadan fasting on intraocular pressure, tear secretion, corneal and anterior chamber parameters. Eye (Lond) 24:97–100
Carney LG, Hill RM (1976) Human tear pH. Diurnal variations. Arch Ophthalmol 94:821–824
Patel S, Bevan R, Farrell JC (1988) Diurnal variation in precorneal tear film stability. Am J Optom Physiol Opt 65:151–154
Cedarstaff TH, Tomlinson A (1983) Human tear volume, quality and evaporation: a comparison of Schirmer, tear break-up time and resistance hygrometry techniques. Ophthalmic Physiol Opt 3:239–245
(2007) Management and therapy of dry eye disease: report of the Management and Therapy Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf 5: 163–178
Siak JJ, Tong L, Wong WL, Cajucom-Uy H, Rosman M, Saw SM, Wong TY (2012) Prevalence and risk factors of Meibomian gland dysfunction: the Singapore Malay Eye Study. Cornea 31(11):1223–1228
Schaumberg DA, Nichols JJ, Papas EB, Tong L, Uchino M, Nichols KK (2011) The international workshop on meibomian gland dysfunction: report of the subcommittee on the epidemiology of, and associated risk factors for, MGD. Invest Ophthalmol Vis Sci 52:1994–2005
Foulks GN, Borchman D (2010) Meibomian gland dysfunction: the past, present, and future. Eye Contact Lens 36:249–253
Hom MM, Martinson JR, Knapp LL, Paugh JR (1990) Prevalence of Meibomian gland dysfunction. Optom Vis Sci 67:710–712
Nichols KK, Foulks GN, Bron AJ, Glasgow BJ, Dogru M, Tsubota K, Lemp MA, Sullivan DA (2011) The international workshop on meibomian gland dysfunction: executive summary. Invest Ophthalmol Vis Sci 52:1922–1929
Sullivan DA, Sullivan BD, Evans JE, Schirra F, Yamagami H, Liu M, Richards SM, Suzuki T, Schaumberg DA, Sullivan RM, Dana MR (2002) Androgen deficiency, Meibomian gland dysfunction, and evaporative dry eye. Ann N Y Acad Sci 966:211–222
Sullivan DA, Schaumberg DA, Suzuki T, Schirra F, Liu M, Richards S, Sullivan RM, Dana MR, Sullivan BD (2002) Sex steroids, meibomian gland dysfunction and evaporative dry eye in Sjogren’s syndrome. Lupus 11:667
Dougherty JM, McCulley JP (1984) Comparative bacteriology of chronic blepharitis. Br J Ophthalmol 68:524–528
Dougherty JM, McCulley JP (1986) Bacterial lipases and chronic blepharitis. Invest Ophthalmol Vis Sci 27:486–491
McCulley JP, Dougherty JM (1986) Bacterial aspects of chronic blepharitis. Trans Ophthalmol Soc U K 105(Pt 3):314–318
Lee HJ, Chang C (2003) Recent advances in androgen receptor action. Cell Mol Life Sci 60:1613–1622
Sullivan DA, Sullivan BD, Ullman MD, Rocha EM, Krenzer KL, Cermak JM, Toda I, Doane MG, Evans JE, Wickham LA (2000) Androgen influence on the meibomian gland. Invest Ophthalmol Vis Sci 41:3732–3742
Sullivan BD, Evans JE, Cermak JM, Krenzer KL, Dana MR, Sullivan DA (2002) Complete androgen insensitivity syndrome: effect on human meibomian gland secretions. Arch Ophthalmol 120:1689–1699
Sullivan BD, Evans JE, Dana MR, Sullivan DA (2002) Impact of androgen deficiency on the lipid profiles in human meibomian gland secretions. Adv Exp Med Biol 506:449–458
Foulks GN, Bron AJ (2003) Meibomian gland dysfunction: a clinical scheme for description, diagnosis, classification, and grading. Ocul Surf 1:107–126
Tomlinson A, Bron AJ, Korb DR, Amano S, Paugh JR, Pearce EI, Yee R, Yokoi N, Arita R, Dogru M (2011) The international workshop on meibomian gland dysfunction: report of the diagnosis subcommittee. Invest Ophthalmol Vis Sci 52:2006–2049
Golebiowski B, Chim K, So J, Jalbert I (2012) Lid margins: sensitivity, staining, meibomian gland dysfunction, and symptoms. Optom Vis Sci 89:e1443–e1449
Powell DR, Nichols JJ, Nichols KK (2012) Inter-examiner reliability in meibomian gland dysfunction assessment. Invest Ophthalmol Vis Sci 53:3120–3125
Nichols JJ, Berntsen DA, Mitchell GL, Nichols KK (2005) An assessment of grading scales for meibography images. Cornea 24:382–388
Pult H, Riede-Pult B (2013) Comparison of subjective grading and objective assessment in meibography. Contact Lens Anterior Eye J Br Contact Lens Assoc 36:22–27
Koh YW, Celik T, Lee HK, Petznick A, Tong L (2012) Detection of meibomian glands and classification of meibography images. J Biomed Opt 17:086008
Hwang HS, Shin JG, Lee BH, Eom TJ, Joo CK (2013) In vivo 3D meibography of the human eyelid using real time imaging fourier-domain OCT. PloS One 8:e67143
Goto E, Shimazaki J, Monden Y, Takano Y, Yagi Y, Shimmura S, Tsubota K (2002) Low-concentration homogenized castor oil eye drops for noninflamed obstructive meibomian gland dysfunction. Ophthalmology 109:2030–2035
Korb DR, Henriquez AS (1980) Meibomian gland dysfunction and contact lens intolerance. J Am Optom Assoc 51:243–251
Dougherty JM, Osgood JK, McCulley JP (1991) The role of wax and sterol ester fatty acids in chronic blepharitis. Invest Ophthalmol Vis Sci 32:1932–1937
Shine WE, McCulley JP (1993) Role of wax ester fatty alcohols in chronic blepharitis. Invest Ophthalmol Vis Sci 34:3515–3521
McCulley JP, Shine WE (2004) The lipid layer of tears: dependent on meibomian gland function. Exp Eye Res 78:361–365
Suzuki T, Sano Y, Sasaki O, Kinoshita S (2002) Ocular surface inflammation induced by Propionibacterium acnes. Cornea 21:812–817
Freedberg IM, Tomic-Canic M, Komine M, Blumenberg M (2001) Keratins and the keratinocyte activation cycle. J Invest Dermatol 116:633–640
Mathers WD (1993) Ocular evaporation in meibomian gland dysfunction and dry eye. Ophthalmology 100:347–351
Mathers WD, Lane JA (1998) Meibomian gland lipids, evaporation, and tear film stability. Adv Exp Med Biol 438:349–360
Shimazaki J, Sakata M, Tsubota K (1995) Ocular surface changes and discomfort in patients with meibomian gland dysfunction. Arch Ophthalmol 113:1266–1270
Lee SH, Tseng SC (1997) Rose bengal staining and cytologic characteristics associated with lipid tear deficiency. Am J Ophthalmol 124:736–750
Yokoi N, Mossa F, Tiffany JM, Bron AJ (1999) Assessment of meibomian gland function in dry eye using meibometry. Arch Ophthalmol 117:723–729
Goto E, Monden Y, Takano Y, Mori A, Shimmura S, Shimazaki J, Tsubota K (2002) Treatment of non-inflamed obstructive meibomian gland dysfunction by an infrared warm compression device. Br J Ophthalmol 86:1403–1407
Matsumoto Y, Dogru M, Goto E, Ishida R, Kojima T, Onguchi T, Yagi Y, Shimazaki J, Tsubota K (2006) Efficacy of a new warm moist air device on tear functions of patients with simple meibomian gland dysfunction. Cornea 25:644–650
Matsumoto Y, Sato EA, Ibrahim OM, Dogru M, Tsubota K (2008) The application of in vivo laser confocal microscopy to the diagnosis and evaluation of meibomian gland dysfunction. Mol Vis 14:1263–1271
Arita R, Itoh K, Maeda S, Maeda K, Furuta A, Fukuoka S, Tomidokoro A, Amano S (2009) Proposed diagnostic criteria for obstructive meibomian gland dysfunction. Ophthalmology 116:2058.e1–2063.e1
Romero JM, Biser SA, Perry HD, Levinson DH, Doshi SJ, Terraciano A, Donnenfeld ED (2004) Conservative treatment of meibomian gland dysfunction. Eye Contact Lens 30:14–19
Prabhasawat P, Tesavibul N, Mahawong W (2012) A randomized double-masked study of 0.05% cyclosporine ophthalmic emulsion in the treatment of meibomian gland dysfunction. Cornea 31:1386–1393
Goto E, Endo K, Suzuki A, Fujikura Y, Tsubota K (2002) Improvement of tear stability following warm compression in patients with meibomian gland dysfunction. Adv Exp Med Biol 506:1149–1152
Olson MC, Korb DR, Greiner JV (2003) Increase in tear film lipid layer thickness following treatment with warm compresses in patients with meibomian gland dysfunction. Eye Contact lens 29:96–99
Lane SS, DuBiner HB, Epstein RJ, Ernest PH, Greiner JV, Hardten DR, Holland EJ, Lemp MA, McDonald JE 2nd, Silbert DI, Blackie CA, Stevens CA, Bedi R (2012) A new system, the LipiFlow, for the treatment of meibomian gland dysfunction. Cornea 31:396–404
Greiner JV (2013) Long-term (12-month) improvement in meibomian gland function and reduced dry eye symptoms with a single thermal pulsation treatment. Clin Exp Ophthalmol 41:524–530
Greiner JV (2012) A single LipiFlow(R) Thermal Pulsation System treatment improves meibomian gland function and reduces dry eye symptoms for 9 months. Curr Eye Res 37:272–278
Friedland BR, Fleming CP, Blackie CA, Korb DR (2011) A novel thermodynamic treatment for meibomian gland dysfunction. Curr Eye Res 36:79–87
Korb DR, Blackie CA (2010) Restoration of meibomian gland functionality with novel thermodynamic treatment device—a case report. Cornea 29:930–933
Korb DR, Blackie CA (2013) Case report: a successful lipiflow treatment of a single case of Meibomian gland dysfunction and dropout. Eye Contact Lens 39(3):e1–e3
Guillon M, Maissa C, Wong S (2012) Eyelid margin modification associated with eyelid hygiene in anterior blepharitis and meibomian gland dysfunction. Eye Contact Lens 38:319–325
Guillon M, Maissa C, Wong S (2012) Symptomatic relief associated with eyelid hygiene in anterior blepharitis and MGD. Eye Contact Lens 38:306–312
Sanchez J, Somolinos AL, Almodovar PI, Webster G, Bradshaw M, Powala C (2005) A randomized, double-blind, placebo-controlled trial of the combined effect of doxycycline hyclate 20-mg tablets and metronidazole 0.75% topical lotion in the treatment of rosacea. J Am Acad Dermatol 53:791–797
Frucht-Pery J, Sagi E, Hemo I, Ever-Hadani P (1993) Efficacy of doxycycline and tetracycline in ocular rosacea. Am J Ophthalmol 116:88–92
Yoo SE, Lee DC, Chang MH (2005) The effect of low-dose doxycycline therapy in chronic meibomian gland dysfunction. Korean J Ophthalmol 19:258–263
Theobald K, Bradshaw M, Leyden J (2007) Anti-inflammatory dose doxycycline (40 mg controlled-release) confers maximum anti-inflammatory efficacy in rosacea. Skinmed 6:221–226
Del Rosso JQ, Webster GF, Jackson M, Rendon M, Rich P, Torok H, Bradshaw M (2007) Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosacea. J Am Acad Dermatol 56:791–802
Lee H, Min K, Kim EK, Kim TI (2012) Minocycline controls clinical outcomes and inflammatory cytokines in moderate and severe Meibomian gland dysfunction. Am J Ophthalmol 154(6):949.e1–957.e1
Foulks GN, Borchman D, Yappert M, Kakar S (2013) Topical azithromycin and oral doxycycline therapy of meibomian gland dysfunction: a comparative clinical and spectroscopic pilot study. Cornea 32(1):44–53
Dougherty JM, McCulley JP, Silvany RE, Meyer DR (1991) The role of tetracycline in chronic blepharitis. Inhibition of lipase production in staphylococci. Invest Ophthalmol Vis Sci 32:2970–2975
Duerden JM, Tiffany JM (1990) Lipid synthesis in vitro by rabbit Meibomian gland tissue and its inhibition by tetracycline. Biochim Biophys Acta 1042:13–18
Shine WE, McCulley JP, Pandya AG (2003) Minocycline effect on meibomian gland lipids in meibomianitis patients. Exp Eye Res 76:417–420
Souchier M, Joffre C, Gregoire S, Bretillon L, Muselier A, Acar N, Beynat J, Bron A, D’Athis P, Creuzot-Garcher C (2008) Changes in meibomian fatty acids and clinical signs in patients with meibomian gland dysfunction after minocycline treatment. Br J Ophthalmol 92:819–822
Nelson M, Hillen W, Greenwald RA (eds) (2001) Tetracyclines in biology, chemistry and medicine. Springer, Germany, 336 p
Yamaryo T, Oishi K, Yoshimine H, Tsuchihashi Y, Matsushima K, Nagatake T (2003) Fourteen-member macrolides promote the phosphatidylserine receptor-dependent phagocytosis of apoptotic neutrophils by alveolar macrophages. Antimicrob Agents Chemother 47:48–53
Sanz MJ, Nabah YN, Cerda-Nicolas M, O’Connor JE, Issekutz AC, Cortijo J, Morcillo EJ (2005) Erythromycin exerts in vivo anti-inflammatory activity downregulating cell adhesion molecule expression. Br J Pharmacol 144:190–201
Xu G, Fujita J, Negayama K, Yuube K, Hojo S, Yamaji Y, Kawanishi K, Takahara J (1996) Effect of macrolide antibiotics on macrophage functions. Microbiol Immunol 40:473–479
Bouwman JJ, Visseren FL, Bouter PK, Diepersloot RJ (2004) Azithromycin inhibits interleukin-6 but not fibrinogen production in hepatocytes infected with cytomegalovirus and chlamydia pneumoniae. J Lab Clin Med 144:18–26
Foulks GN, Borchman D, Yappert M, Kim SH, McKay JW (2010) Topical azithromycin therapy for meibomian gland dysfunction: clinical response and lipid alterations. Cornea 29:781–788
Luchs J (2010) Azithromycin in DuraSite for the treatment of blepharitis. Clin Ophthalmol 4:681–688
Akyol-Salman I, Azizi S, Mumcu UY, Ates O, Baykal O (2011) Comparison of the efficacy of topical N-acetyl-cysteine and a topical steroid-antibiotic combination therapy in the treatment of meibomian gland dysfunction. J Ocul Pharmacol Ther 28:49–52
Matsumoto Y, Shigeno Y, Sato EA, Ibrahim OM, Saiki M, Negishi K, Ogawa Y, Dogru M, Tsubota K (2009) The evaluation of the treatment response in obstructive meibomian gland disease by in vivo laser confocal microscopy. Graefes Arch Clin Exp Ophthalmol 247:821–829
Lindsley K, Matsumura S, Hatef E, Akpek EK (2012) Interventions for chronic blepharitis. Cochrane Database Syst Rev 5, CD005556
Hamrah P, Qazi Y, Blackie CA, Korb DR (2012) Subclinical inflammation may explain the persistence of refractory dry eye symptoms after apparently successful treatment for meibomian gland dysfunction. ARVO Meeting Abstracts 53(6):594
Villani E, Ceresara G, Beretta S, Magnani F, Viola F, Ratiglia R (2011) In vivo confocal microscopy of meibomian glands in contact lens wearers. Invest Ophthalmol Vis Sci 52:5215–5219
Villani E, Beretta S, De Capitani M, Galimberti D, Viola F, Ratiglia R (2010) In vivo confocal microscopy of meibomian glands in Sjogren’s syndrome. Invest Ophthalmol Vis Sci 52:933–939
Ibrahim OM, Matsumoto Y, Dogru M, Adan ES, Wakamatsu TH, Shimazaki J, Fujishima H, Tsubota K (2012) In vivo confocal microscopy evaluation of meibomian gland dysfunction in atopic-keratoconjunctivitis patients. Ophthalmology 119:1961–1968
Wei A, Hong J, Sun X, Xu J (2011) Evaluation of age-related changes in human palpebral conjunctiva and meibomian glands by in vivo confocal microscopy. Cornea 30:1007–1012
Kobayashi A, Yoshita T, Sugiyama K (2005) In vivo findings of the bulbar/palpebral conjunctiva and presumed meibomian glands by laser scanning confocal microscopy. Cornea 24:985–988
Cavanagh HD, Jester JV, Essepian J, Shields W, Lemp MA (1990) Confocal microscopy of the living eye. CLAO J 16:65–73
Bohnke M, Masters BR (1999) Confocal microscopy of the cornea. Prog Retin Eye Res 18:553–628
Efron N, Al-Dossari M, Pritchard N (2009) In vivo confocal microscopy of the palpebral conjunctiva and tarsal plate. Optom Vis Sci 86:E1303–E1308
Muller LJ, Marfurt CF, Kruse F, Tervo TM (2003) Corneal nerves: structure, contents and function. Exp Eye Res 76:521–542
Grupcheva CN, Wong T, Riley AF, McGhee CN (2002) Assessing the sub-basal nerve plexus of the living healthy human cornea by in vivo confocal microscopy. Clin Exp Ophthalmol 30:187–190
Oliveira-Soto L, Efron N (2001) Morphology of corneal nerves using confocal microscopy. Cornea 20:374–384
Marfurt CF, Cox J, Deek S, Dvorscak L (2010) Anatomy of the human corneal innervation. Exp Eye Res 90:478–492
Tuominen IS, Konttinen YT, Vesaluoma MH, Moilanen JA, Helinto M, Tervo TM (2003) Corneal innervation and morphology in primary Sjogren’s syndrome. Invest Ophthalmol Vis Sci 44:2545–2549
Villani E, Galimberti D, Viola F, Mapelli C, Ratiglia R (2007) The cornea in Sjogren’s syndrome: an in vivo confocal study. Invest Ophthalmol Vis Sci 48:2017–2022
Erdelyi B, Kraak R, Zhivov A, Guthoff R, Nemeth J (2007) In vivo confocal laser scanning microscopy of the cornea in dry eye. Graefes Arch Clin Exp Ophthalmol 245:39–44
Zhang X, Chen Q, Chen W, Cui L, Ma H, Lu F (2011) Tear dynamics and corneal confocal microscopy of subjects with mild self-reported office dry eye. Ophthalmology 118:902–907
Benitez del Castillo JM, Wasfy MA, Fernandez C, Garcia-Sanchez J (2004) An in vivo confocal masked study on corneal epithelium and subbasal nerves in patients with dry eye. Invest Ophthalmol Vis Sci 45:3030–3035
Vera LS, Gueudry J, Delcampe A, Roujeau JC, Brasseur G, Muraine M (2009) In vivo confocal microscopic evaluation of corneal changes in chronic Stevens–Johnson syndrome and toxic epidermal necrolysis. Cornea 28:401–407
Hamrah P, Zhang Q, Liu Y, Dana MR (2002) Novel characterization of MHC class II-negative population of resident corneal Langerhans cell-type dendritic cells. Invest Ophthalmol Vis Sci 43:639–646
Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392:245–252
Tuisku IS, Konttinen YT, Konttinen LM, Tervo TM (2008) Alterations in corneal sensitivity and nerve morphology in patients with primary Sjogren’s syndrome. Exp Eye Res 86:879–885
Zhivov A, Stave J, Vollmar B, Guthoff R (2005) In vivo confocal microscopic evaluation of Langerhans cell density and distribution in the normal human corneal epithelium. Graefes Arch Clin Exp Ophthalmol 243:1056–1061
Lin H, Li W, Dong N, Chen W, Liu J, Chen L, Yuan H, Geng Z, Liu Z (2010) Changes in corneal epithelial layer inflammatory cells in aqueous tear-deficient dry eye. Invest Ophthalmol Vis Sci 51:122–128
Cruzat A, Witkin D, Baniasadi N, Zheng L, Ciolino JB, Jurkunas UV, Chodosh J, Pavan-Langston D, Dana R, Hamrah P (2011) Inflammation and the nervous system: the connection in the cornea in patients with infectious keratitis. Invest Ophthalmol Vis Sci 52:5136–5143
Benitez-Del-Castillo JM, Acosta MC, Wassfi MA, Diaz-Valle D, Gegundez JA, Fernandez C, Garcia-Sanchez J (2007) Relation between corneal innervation with confocal microscopy and corneal sensitivity with noncontact esthesiometry in patients with dry eye. Invest Ophthalmol Vis Sci 48:173–181
Zhang M, Chen J, Luo L, Xiao Q, Sun M, Liu Z (2005) Altered corneal nerves in aqueous tear deficiency viewed by in vivo confocal microscopy. Cornea 24:818–824
Labbe A, Alalwani H, Van Went C, Brasnu E, Georgescu D, Baudouin C (2012) The relationship between subbasal nerve morphology and corneal sensation in ocular surface disease. Invest Ophthalmol Vis Sci 53:4926–4931
Bourcier T, Acosta MC, Borderie V, Borras F, Gallar J, Bury T, Laroche L, Belmonte C (2005) Decreased corneal sensitivity in patients with dry eye. Invest Ophthalmol Vis Sci 46:2341–2345
Xu KP, Yagi Y, Tsubota K (1996) Decrease in corneal sensitivity and change in tear function in dry eye. Cornea 15:235–239
Hosal BM, Ornek N, Zilelioglu G, Elhan AH (2005) Morphology of corneal nerves and corneal sensation in dry eye: a preliminary study. Eye (Lond) 19:1276–1279
De Paiva CS, Pflugfelder SC (2004) Corneal epitheliopathy of dry eye induces hyperesthesia to mechanical air jet stimulation. Am J Ophthalmol 137:109–115
Stevenson W, Chauhan SK, Dana R (2012) Dry eye disease: an immune-mediated ocular surface disorder. Arch Ophthalmol 130:90–100
Zheng X, de Paiva CS, Li DQ, Farley WJ, Pflugfelder SC (2010) Desiccating stress promotion of Th17 differentiation by ocular surface tissues through a dendritic cell-mediated pathway. Invest Ophthalmol Vis Sci 51:3083–3091
Li S, Sack R, Vijmasi T, Sathe S, Beaton A, Quigley D, Gallup M, McNamara NA (2008) Antibody protein array analysis of the tear film cytokines. Optom Vis Sci 85:653–660
Solomon A, Dursun D, Liu Z, Xie Y, Macri A, Pflugfelder SC (2001) Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. Invest Ophthalmol Vis Sci 42:2283–2292
Katsifis GE, Rekka S, Moutsopoulos NM, Pillemer S, Wahl SM (2009) Systemic and local interleukin-17 and linked cytokines associated with Sjogren’s syndrome immunopathogenesis. Am J Pathol 175:1167–1177
Kang MH, Kim MK, Lee HJ, Lee HI, Wee WR, Lee JH (2011) Interleukin-17 in various ocular surface inflammatory diseases. J Korean Med Sci 26:938–944
Massingale ML, Li X, Vallabhajosyula M, Chen D, Wei Y, Asbell PA (2009) Analysis of inflammatory cytokines in the tears of dry eye patients. Cornea 28:1023–1027
Pflugfelder SC, de Paiva CS, Li DQ, Stern ME (2008) Epithelial-immune cell interaction in dry eye. Cornea 27(Suppl 1):S9–S11
Garcia-Hirschfeld J, Lopez-Briones LG, Belmonte C (1994) Neurotrophic influences on corneal epithelial cells. Exp Eye Res 59:597–605
Beuerman RW, Schimmelpfennig B (1980) Sensory denervation of the rabbit cornea affects epithelial properties. Exp Neurol 69:196–201
Beuerman RW, Stern ME (2005) Neurogenic inflammation: a first line of defense for the ocular surface. Ocul Surf 3:S203–S206
Belmonte C, Acosta MC, Gallar J (2004) Neural basis of sensation in intact and injured corneas. Exp Eye Res 78:513–525
Avetisov SE, Borodina NV, Safonova TN, Fedorov AA, Lutsevich EE, Matevosova EA, Malozhen SA (2009) Potentialities of confocal microscopy in the evaluation of the cornea in the dry eye syndrome. Vestn Oftalmol 125:52–54
Labbe A, Liang Q, Wang Z, Zhang Y, Xu L, Baudouin C, Sun X (2013) Corneal nerve structure and function in patients with non-sjogren dry eye: clinical correlations. Invest Ophthalmol Vis Sci 54:5144–5150
Ibrahim OM, Matsumoto Y, Dogru M, Adan ES, Wakamatsu TH, Goto T, Negishi K, Tsubota K (2010) The efficacy, sensitivity, and specificity of in vivo laser confocal microscopy in the diagnosis of meibomian gland dysfunction. Ophthalmology 117:665–672
Qazi Y, Cavalcanti B, Cruzat A, Cheng S, Williams C, Trinidad M, Witkin D, Blackie CA, Korb DR, Hamrah P (2012) Immune response in meibomian gland dysfunction (MGD) and the effect of anti-inflammatory therapy: an in vivo confocal microscopy (IVCM) study. ARVO Meeting Abstracts 53
Qazi Y, Cavalcanti BC, Cruzat A, Trinidad M, Williams C, Blackie CA, Korb DR, Hamrah P (2012) Symptomatic, clinical and imaging response following anti-inflammatory therapy for Meibomian Gland Dysfunction (MGD); Chicago. pp. page 186
Maskin SL (2010) Intraductal meibomian gland probing relieves symptoms of obstructive meibomian gland dysfunction. Cornea 29:1145–1152
Wladis EJ (2012) Intraductal meibomian gland probing in the management of ocular rosacea. Ophthal Plast Reconstr Surg 28(6):416–418
Huang D, Swanson EA, Lin CP, Schuman JS, Stinson WG, Chang W, Hee MR, Flotte T, Gregory K, Puliafito CA et al (1991) Optical coherence tomography. Science 254:1178–1181
Zhou Y, Tian L, Wang N, Dougherty PJ (2011) Anterior segment optical coherence tomography measurement of LASIK flaps: femtosecond laser vs microkeratome. J Refract Surg 27:408–416
Werner L, Michelson J, Ollerton A, Leishman L, Bodnar Z (2012) Anterior segment optical coherence tomography in the assessment of postoperative intraocular lens optic changes. J Cataract Refract Surg 38:1077–1085
Zhang XX, Zhong XW, Wu JS, Wang Z, Yu KM, Liu Q, Yang B (2012) Corneal flap morphological analysis using anterior segment optical coherence tomography in laser in situ keratomileusis with femtosecond lasers versus mechanical microkeratome. Int J Ophthalmol 5:69–73
Shabana N, Aquino MC, See J, Ce Z, Tan AM, Nolan WP, Hitchings R, Young SM, Loon SC, Sng CC, Wong W, Chew PT (2012) Quantitative evaluation of anterior chamber parameters using anterior segment optical coherence tomography in primary angle closure mechanisms. Clin Exp Ophthalmol 40:792–801
Sayegh RR, Pineda R 2nd (2012) Practical applications of anterior segment optical coherence tomography imaging following corneal surgery. Semin Ophthalmol 27:125–132
Salim S (2012) The role of anterior segment optical coherence tomography in glaucoma. J Ophthalmol 2012:476801
Majander AS, Lindahl PM, Vasara LK, Krootila K (2012) Anterior segment optical coherence tomography in congenital corneal opacities. Ophthalmology 119:2450–2457
Jhanji V, Constantinou M, Beltz J, Vajpayee RB (2011) Evaluation of posterior wound profile after penetrating keratoplasty using anterior segment optical coherence tomography. Cornea 30:277–280
Aptel F, Beccat S, Fortoul V, Denis P (2011) Biometric analysis of pigment dispersion syndrome using anterior segment optical coherence tomography. Ophthalmology 118:1563–1570
Gumus K, Crockett CH, Pflugfelder SC (2010) Anterior segment optical coherence tomography: a diagnostic instrument for conjunctivochalasis. Am J Ophthalmol 150:798–806
Ibrahim OM, Dogru M, Takano Y, Satake Y, Wakamatsu TH, Fukagawa K, Tsubota K, Fujishima H (2010) Application of visante optical coherence tomography tear meniscus height measurement in the diagnosis of dry eye disease. Ophthalmology 117:1923–1929
Lim LS, Aung HT, Aung T, Tan DT (2008) Corneal imaging with anterior segment optical coherence tomography for lamellar keratoplasty procedures. Am J Ophthalmol 145:81–90
Sarunic MV, Asrani S, Izatt JA (2008) Imaging the ocular anterior segment with real-time, full-range Fourier-domain optical coherence tomography. Arch Ophthalmol 126:537–542
Asrani S, Sarunic M, Santiago C, Izatt J (2008) Detailed visualization of the anterior segment using fourier-domain optical coherence tomography. Arch Ophthalmol 126:765–771
Radhakrishnan S, Rollins AM, Roth JE, Yazdanfar S, Westphal V, Bardenstein DS, Izatt JA (2001) Real-time optical coherence tomography of the anterior segment at 1310 nm. Arch Ophthalmol 119:1179–1185
Gora M, Karnowski K, Szkulmowski M, Kaluzny BJ, Huber R, Kowalczyk A, Wojtkowski M (2009) Ultra high-speed swept source OCT imaging of the anterior segment of human eye at 200 kHz with adjustable imaging range. Opt Express 17:14880–14894
Jungwirth J, Baumann B, Pircher M, Gotzinger E, Hitzenberger CK (2009) Extended in vivo anterior eye-segment imaging with full-range complex spectral domain optical coherence tomography. J Biomed Opt 14:050501
Hutchings N, Simpson TL, Hyun C, Moayed AA, Hariri S, Sorbara L, Bizheva K (2010) Swelling of the human cornea revealed by high-speed, ultrahigh-resolution optical coherence tomography. Invest Ophthalmol Vis Sci 51:4579–4584
Bizheva K, Lee P, Sorbara L, Hutchings N, Simpson T (2010) In vivo volumetric imaging of the human upper eyelid with ultrahigh-resolution optical coherence tomography. J Biomed Opt 15:040508
Qiu X, Gong L, Lu Y, Jin H, Robitaille M (2012) The diagnostic significance of Fourier-domain optical coherence tomography in Sjogren syndrome, aqueous tear deficiency and lipid tear deficiency patients. Acta Ophthalmol 90:e359–e366
Qiu X, Gong L, Sun X, Jin H (2010) Age-related variations of human tear meniscus and diagnosis of dry eye with Fourier-domain anterior segment optical coherence tomography. Cornea 30:543–549
Nguyen P, Huang D, Li Y, Sadda SR, Ramos S, Pappuru RR, Yiu SC (2012) Correlation between optical coherence tomography-derived assessments of lower tear meniscus parameters and clinical features of dry eye disease. Cornea 31:680–685
Ibrahim OM, Dogru M, Kojima T, Matsumoto Y, Wakamatsu TH, Tsubota K, Fujishima H (2012) OCT assessment of tear meniscus after punctal occlusion in dry eye disease. Optom Vis Sci 89:E770–E776
Altan-Yaycioglu R, Sizmaz S, Canan H, Coban-Karatas M (2013) Optical coherence tomography for measuring the tear film meniscus: correlation with Schirmer test and tear-film breakup time. Curr Eye Res 38:736–742
Werkmeister RM, Alex A, Kaya S, Unterhuber A, Hofer B, Riedl J, Bronhagl M, Vietauer M, Schmidl D, Schmoll T, Garhofer G, Drexler W, Leitgeb RA, Groeschl M, Schmetterer L (2013) Measurement of tear film thickness using ultrahigh-resolution optical coherence tomography. Invest Ophthalmol Vis Sci 54:5578–5583
Chen Q, Zhang X, Cui L, Huang Q, Chen W, Ma H, Lu F (2011) Upper and lower tear menisci in Sjogren’s syndrome dry eye. Invest Ophthalmol Vis Sci 52:9373–9378
Veres A, Tapaszto B, Kosina-Hagyo K, Somfai GM, Nemeth J (2011) Imaging lid-parallel conjunctival folds with OCT and comparing its grading with the slit lamp classification in dry eye patients and normal subjects. Invest Ophthalmol Vis Sci 52:2945–2951
Tapaszto B, Veres A, Kosina-Hagyo K, Somfai GM, Nemeth J (2011) OCT Imaging of lid-parallel conjunctival folds in soft contact lens wearers. Optom Vis Sci 88:1206–1213
Zeiss C (2009) Visante Omni — a new dimension in anterior segment evaluation (Carl Zeiss Meditech Inc.)
Dartt D, Bex P, D’Amore P, Dana R, Mcloon L, Niederkorn J (2011) Ocular periphery and disorders. Academic Press, Oxford, UK
Bioptigen (2013) Envisu C-Class System Comparison. Bioptigen Inc.
Li Y, Tang M, Zhang X, Salaroli CH, Ramos JL, Huang D (2010) Pachymetric mapping with Fourier-domain optical coherence tomography. J Cataract Refract Surg 36:826–831
Optovue (2008–2013) RTVue: power for your practice
Acknowledgments
We would like to thank our sponsors for their generous support through grants from the National Institute of Health (NIH K08-EY020575 to PH), Research to Prevent Blindness Career Development Award (PH) and Falk Medical Research Foundation (PH).
Conflict of interest
None for all authors.
Author information
Authors and Affiliations
Corresponding author
Additional information
Yureeda Qazi and Shruti Aggarwal contributed equally to this work.
Rights and permissions
About this article
Cite this article
Qazi, Y., Aggarwal, S. & Hamrah, P. Image-guided evaluation and monitoring of treatment response in patients with dry eye disease. Graefes Arch Clin Exp Ophthalmol 252, 857–872 (2014). https://doi.org/10.1007/s00417-014-2618-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-014-2618-2